Swisher Daniel N JR (CIK 0001323113)

Latest company ownership

Shares held
240,177
Last filed at
Jul 12, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2010Q2 2025Q4
Role: Director
Shares held
207,045
Last filed at
Jun 4, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
55,014
Last filed at
Mar 7, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
2,200
Last filed at
Oct 15, 2025
Confidence Score
8.4
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 10, 2025 Oct 15, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $192.6K
Sep 10, 2025 Sep 11, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $159.4K
Aug 11, 2025 Aug 12, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $159.1K
Jul 10, 2025 Jul 14, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $156.4K
Jun 10, 2025 Jun 12, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $155.3K
May 12, 2025 May 14, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $158.5K
Apr 10, 2025 Apr 14, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $154.5K
Mar 10, 2025 Mar 12, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $117.9K
Feb 10, 2025 Feb 12, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $149.8K
Jan 10, 2025 Jan 14, 2025 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $111.2K
Dec 10, 2024 Dec 12, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $130.8K
Nov 11, 2024 Nov 13, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $131.7K
Aug 1, 2024 Aug 5, 2024 CORCEPT THERAPEUTICS INC Director Sell 15.0 -150 -100.00% $5.8K
Jul 1, 2024 Jul 3, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $72.2K
Jun 3, 2024 Jun 5, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $66.5K
May 9, 2024 May 9, 2024 CERUS CORP Director Buy 77.5 +2,500 2.39% $4.7K
May 1, 2024 May 3, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $50.8K
Apr 1, 2024 Apr 3, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $55.7K
Mar 1, 2024 Mar 5, 2024 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $51.9K
Feb 1, 2024 Feb 2, 2024 CORCEPT THERAPEUTICS INC Director Sell 13.8 -2,200 -100.00% $48.4K
Jan 2, 2024 Jan 4, 2024 CORCEPT THERAPEUTICS INC Director Sell 13.8 -2,200 -100.00% $48.6K
Dec 1, 2023 Dec 5, 2023 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $56K
Nov 1, 2023 Nov 3, 2023 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $61.5K
Oct 2, 2023 Oct 4, 2023 CORCEPT THERAPEUTICS INC Director Sell 10.0 -2,200 -100.00% $60.1K
Sep 1, 2023 Sep 6, 2023 CORCEPT THERAPEUTICS INC Director Sell 22.5 -3,750 -100.00% $123.1K
Aug 7, 2023 Aug 9, 2023 CORCEPT THERAPEUTICS INC Director Sell 22.5 -2,850 -100.00% $85.9K
May 26, 2023 May 30, 2023 CERUS CORP Director Buy 82.5 +5,000 4.39% $9.5K
Mar 3, 2023 Mar 7, 2023 Jazz Pharmaceuticals plc COO Sell 97.5 +8,030 17.09% $774.7K
Nov 10, 2022 Nov 14, 2022 CERUS CORP Director Sell 26.3 -12,500 -9.90% $48.9K
Aug 8, 2022 Aug 9, 2022 CORCEPT THERAPEUTICS INC Director Sell 20.0 -20,000 -100.00% $566.7K
Mar 3, 2022 Mar 9, 2022 Jazz Pharmaceuticals plc COO Sell 97.5 +8,705 17.93% $739.3K
Jan 3, 2022 Jan 5, 2022 Jazz Pharmaceuticals plc COO Sell 22.5 -1,624 -3.24% $212.8K
Sep 2, 2021 Sep 3, 2021 CORCEPT THERAPEUTICS INC Director Sell 10.0 -7,500 -100.00% $162.7K
Aug 4, 2021 Aug 5, 2021 CERUS CORP Director Sell 25.0 -12,877 -12.12% $80.5K
Jun 2, 2021 Jun 4, 2021 CORCEPT THERAPEUTICS INC Director Sell 10.0 -7,500 -100.00% $161.1K
May 18, 2021 May 20, 2021 CERUS CORP Director Sell 32.5 -5,000 -7.71% $28.7K
Apr 5, 2021 Apr 7, 2021 CORCEPT THERAPEUTICS INC Director Sell 10.0 -7,500 -100.00% $181K
Mar 5, 2021 Mar 9, 2021 Jazz Pharmaceuticals plc COO Sell 20.0 -3,718 -6.93% $612.5K
Feb 16, 2021 Feb 18, 2021 CERUS CORP Director Sell 25.0 -10,000 -14.31% $77.8K
Jan 19, 2021 Jan 21, 2021 CORCEPT THERAPEUTICS INC Director Sell 10.0 -5,000 -100.00% $143.7K
Jan 4, 2021 Jan 6, 2021 Jazz Pharmaceuticals plc COO Sell 20.0 -1,607 -3.69% $257.8K
Nov 17, 2020 Nov 19, 2020 CERUS CORP Director Sell 25.0 -10,000 -14.31% $62.5K
Oct 19, 2020 Oct 21, 2020 CORCEPT THERAPEUTICS INC Director Sell 10.0 -5,000 -100.00% $88.3K
Jul 17, 2020 Jul 20, 2020 CORCEPT THERAPEUTICS INC Director Sell 10.0 -5,000 -100.00% $82.4K
May 22, 2020 May 27, 2020 CORCEPT THERAPEUTICS INC Director Sell 10.0 -5,000 -100.00% $80.5K
Mar 5, 2020 Mar 9, 2020 Jazz Pharmaceuticals plc COO Sell 22.5 -1,735 -3.84% $216K
Jan 29, 2020 Feb 6, 2020 CERUS CORP Director Buy 77.5 +1,000 2.23% $4.2K
Jan 3, 2020 Jan 6, 2020 Jazz Pharmaceuticals plc COO Sell 22.5 -1,599 -5.20% $233.6K
Jan 3, 2019 Jan 7, 2019 Jazz Pharmaceuticals plc COO Sell 22.5 -1,604 -8.85% $202.1K
Feb 29, 2016 Mar 2, 2016 Viracta Therapeutics, Inc. CEO Sell 91.3 +81,858 21.30% $41.8K
Aug 24, 2015 Aug 26, 2015 Viracta Therapeutics, Inc. CEO Buy 86.3 +25,000 7.06% $25.3K
Jul 24, 2015 Jul 28, 2015 Viracta Therapeutics, Inc. CEO Sell 78.8 +12,285 1.94% $18.5K
Feb 27, 2015 Mar 2, 2015 Viracta Therapeutics, Inc. CEO Sell 86.3 +18,056 6.29% $27.2K
Aug 27, 2014 Aug 29, 2014 Viracta Therapeutics, Inc. CEO Sell 48.8 -5,000 -1.73% $40K
Feb 28, 2014 Mar 4, 2014 Viracta Therapeutics, Inc. CEO Sell 78.8 +6,224 2.48% $24.5K
Feb 28, 2013 Mar 1, 2013 Viracta Therapeutics, Inc. CEO Sell 86.3 +13,162 6.32% $39.8K
Feb 29, 2012 Mar 2, 2012 Viracta Therapeutics, Inc. CEO Buy 91.3 +75,369 34.09% $35.2K
Nov 28, 2011 Nov 30, 2011 Viracta Therapeutics, Inc. CEO Buy 77.5 +2,500 1.52% $2.8K
Nov 21, 2011 Nov 22, 2011 Viracta Therapeutics, Inc. CEO Buy 77.5 +2,100 1.34% $2.5K
Jul 15, 2011 Jul 18, 2011 Viracta Therapeutics, Inc. CEO Buy 82.5 +5,000 3.31% $9.9K
Feb 28, 2011 Mar 2, 2011 Viracta Therapeutics, Inc. CEO Sell 91.3 +22,897 17.84% $27.9K
Jul 30, 2010 Aug 3, 2010 Viracta Therapeutics, Inc. CEO Sell 86.3 +52,876 7.37% $14.9K
Jun 30, 2010 Jul 1, 2010 Viracta Therapeutics, Inc. CEO Buy 95.0 +476,487 1166.35% $131K